Title:
FGFR INHIBITOR COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/152274
Kind Code:
A1
Abstract:
An FGFR inhibitor compound represented by formula (I): [formula (I)].
More Like This:
| WO/2023/168194 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME |
| WO/1993/016703 | PROTEIN KINASE C INHIBITOR |
| JPH09505075 | INDUSTRIAL APPLICABILITY The herbicidal pyrolopyridine compound |
Inventors:
LU LIANG (CN)
ZHAO SAISAI (CN)
HUANG HAI (CN)
ZHANG LONGZHENG (CN)
ZHANG JIXUAN (CN)
CHEN JIAXIN (CN)
LING SHANCUN (CN)
ZHAO SAISAI (CN)
HUANG HAI (CN)
ZHANG LONGZHENG (CN)
ZHANG JIXUAN (CN)
CHEN JIAXIN (CN)
LING SHANCUN (CN)
Application Number:
PCT/CN2022/072149
Publication Date:
July 21, 2022
Filing Date:
January 14, 2022
Export Citation:
Assignee:
SHENZHEN KANGSU PHARMACEUTICAL TECH CO LTD (CN)
International Classes:
C07D487/04; A61K31/4188; A61K31/4545; A61K31/497; A61K31/5377; A61P35/00; C07D519/00
Foreign References:
| CN106317023A | 2017-01-11 | |||
| CN111606908A | 2020-09-01 | |||
| US20140171405A1 | 2014-06-19 | |||
| CN113666911A | 2021-11-19 |
Other References:
STAHLWERMUTH: "Selection and Use", 2002, WILEY-VCH, article "Handbook of Pharmaceutical Salts: Properties"
Attorney, Agent or Firm:
BEIJING EAST IP LTD. (CN)
Download PDF: